Track topics on Twitter Track topics that are important to you
A deal worth $2.1 billion has been struck between Johnson & Johnson (J&J) and the firm behind the world-leading glucose monitoring system. Platinum Equity, whose business LifeScan Inc makes the OneTouch devices, made the binding offer to J...
Original Article: J&J seals deal on purchase of major diabetes devices firmNEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...